Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 50 (2) , 353-362
Abstract
No abstract availableKeywords
Funding Information
- Natural Sciences and Engineering Council of Canada (NSERC) (RGPIN 250139)
- the National Institutes of Environmental Health Sciences research (R01ES07685)
This publication has 52 references indexed in Scilit:
- Inhibition of Human Cytochrome P450 Enzymes 3A4 and 2D6 by β‐Carboline Alkaloids, Harmine DerivativesPhytotherapy Research, 2011
- Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanismToxicology and Applied Pharmacology, 2010
- CH223191 Is a Ligand-Selective Antagonist of the Ah (Dioxin) ReceptorToxicological Sciences, 2010
- Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic modelBiochemical Pharmacology, 2009
- Resveratrol Inhibits Dioxin-Induced Expression of Human CYP1A1 and CYP1B1 by Inhibiting Recruitment of the Aryl Hydrocarbon Receptor Complex and RNA Polymerase II to the Regulatory Regions of the Corresponding GenesToxicological Sciences, 2009
- Effect of Peganum harmala or its β‐carboline alkaloids on certain antibiotic resistant strains of bacteria and protozoa from poultryPhytotherapy Research, 2008
- Specific blockage of ligand-induced degradation of the Ah receptor by proteasome but not calpain inhibitors in cell culture lines from different speciesBiochemical Pharmacology, 2007
- CYP1A1, Cigarette Smoking, and Colon and Rectal CancerAmerican Journal of Epidemiology, 2004
- Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyreneJournal of Applied Toxicology, 2003
- Ah receptor for 2,3,7,8‐tetrachlorodibenzo‐p‐dioxinEuropean Journal of Biochemistry, 1986